PTC Therapeutics CEO Stuart Peltz's 2018 pay jumps 85% to $4M
PTC Therapeutics reports 2018 executive compensation
By ExecPay News
Published: April 25, 2019
PTC Therapeutics reported fiscal year 2018 executive compensation information on April 25, 2019.
In 2018, five executives at PTC Therapeutics received on average a compensation package of $2.1M, a 71% increase compared to previous year.
Average pay of disclosed executives at PTC Therapeutics
Stuart W. Peltz, Chief Executive Officer, received $4M in total, which increased by 85% compared to 2017. 60% of Peltz's compensation, or $2.4M, was in option awards. Peltz also received $922K in non-equity incentive plan, $659K in salary, as well as $14K in other compensation.
Marcio Souza, Chief Operating Officer, received a compensation package of $1.9M, which increased by 28% compared to previous year. 49% of the compensation package, or $953K, was in option awards.
Neil Almstead, Chief Technical Operations Officer, earned $1.6M in 2018, a 69% increase compared to previous year.
Mark E. Boulding, Chief Legal Officer, received $1.6M in 2018, which increases by 43% compared to 2017.
Christine Utter, Principal Financial Officer and Treasurer, earned $1.1M in 2018, a 32% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 25, 2019.